Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer

Mark Garzotto, Celestia S. Higano, Catherine O'Brien, Brooks L.S. Rademacher, Nicole Janeba, Ladan Fazli, Paul H. Lange, Stephen Lieberman, Tomasz M. Beer

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences